Analysis of PFS2 by subsequent therapy in KEYNOTE-361: Pembrolizumab (pembro) plus chemotherapy (chemo) or pembro alone versus chemo as 1L therapy for advanced urothelial carcinoma (UC).

被引：0

作者：

Ozguroglu, Mustafa ^{[1
]}

Alva, Ajjai Shivaram ^{[2
]}

Csoszi, Tibor ^{[3
]}

Matsubara, Nobuaki ^{[4
]}

Geczi, Lajos ^{[5
]}

Cheng, Susanna Y. ^{[6
]}

Fradet, Yves ^{[7
]}

Oudard, Stephane ^{[8
]}

Vulsteke, Christof ^{[9
]}

Morales-Barrera, Rafael ^{[10
]}

Flechon, Aude ^{[11
]}

Gunduz, Seyda ^{[12
]}

Loriot, Yohann ^{[13
]}

Rodriguez-Vida, Alejo ^{[14
]}

Mamtani, Ronac ^{[15
]}

Yu, Evan Y. ^{[16
]}

Nam, Kijoeng ^{[17
]}

Imai, Kentaro ^{[17
]}

Moreno, Blanca Homet ^{[17
]}

Powles, Thomas ^{[18
]}

机构：

[1] Istanbul Univ Cerrahpasa, Cerrahpasa Med Sch, Istanbul, Turkey

[2] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[3] Hetenyi G Korhaz, Szolnok, Hungary

[4] Natl Canc Ctr Hosp East, Div Breast & Med Oncol, Chiba, Japan

[5] Natl Inst Oncol, Budapest, Hungary

[6] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada

[7] Univ Laval, CHU Quebec, Quebec City, PQ, Canada

[8] Univ Paris, Hop Europeen Georges Pompidou, AP HP, Dept Oncol, Paris, France

[9] Univ Antwerp, Integrated Canc Ctr Ghent, Ctr Oncol Res CORE, Ghent, Belgium

[10] Vall dHebron Inst Oncol, Barcelona, Spain

[11] Ctr Leon Berard, Dept Med Oncol, Lyon, France

[12] Akdeniz Univ, Antalya, Turkey

[13] Univ Paris Saclay, Inst Gustave Roussy, Dept Canc Med, Villejuif, France

[14] Hosp del Mar Res Inst, Dept Med Oncol, Barcelona, Spain

[15] Univ Penn, Philadelphia, PA 19104 USA

[16] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA

[17] Merck & Co Inc, Kenilworth, NJ USA

[18] Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期

关键词：

D O I：

10.1200/JCO.2021.39.6_suppl.448

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

448

引用

页数：4